Condition: Neovascular (Wet) Age-Related Macular Degeneration · Sponsor: 4D Molecular Therapeutics
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and tolerability of 4D-150 contralateral eye dosing and characterize vector shedding.
This description comes directly from the study's public registry record.
4DMT Patient Advocacy · (888) 748-8881 · clinicaltrials@4DMT.com
Always discuss trial participation with your own doctor first.
| Barnet Delaney Perkins Eye Center | Phoenix, Arizona, United States | Recruiting |
| California Retina Consultants | Oxnard, California, United States | Recruiting |
| Retinal Consultants Medical Group | Sacramento, California, United States | Recruiting |
| Colorado Retina Associates | Lakewood, Colorado, United States | Recruiting |
| Rand Eye Institute | Deerfield Beach, Florida, United States | Suspended |
| Retina Vitreous Consultants, LLP DBA Retina Group of Florida | Fort Lauderdale, Florida, United States | Active Not Recruiting |
| Vitreo Retinal Associates | Gainesville, Florida, United States | Recruiting |
| Florida Eye Associates | Melbourne, Florida, United States | Recruiting |
| Retinal Specialty Institute | Pensacola, Florida, United States | Recruiting |
| Retina Vitreous Associates of Florida | Tampa, Florida, United States | Recruiting |
| University Retina and Macula Associates | Oak Forest, Illinois, United States | Recruiting |
| Retina Partners Midwest | Carmel, Indiana, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05197270